EICHOR
● Active Not Recruiting
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Condition: Gliosarcoma · Recurrent Glioblastoma · Sponsor: ECOG-ACRIN Cancer Research Group
About this study
This phase II trial studies how well dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) works in measuring relative cerebral blood volume (rCBV) for early response to bevacizumab in patients with glioblastoma that has come back. DSC-MRI may help evaluate changes in the blood vessels within the cancer to determine a patient?s response to treatment.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (58)
| Saint Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| Mayo Clinic Hospital | Phoenix, Arizona, United States | — |
| Mayo Clinic in Arizona | Scottsdale, Arizona, United States | — |
| Eden Hospital Medical Center | Castro Valley, California, United States | — |
| Loma Linda University Medical Center | Loma Linda, California, United States | — |
| USC / Norris Comprehensive Cancer Center | Los Angeles, California, United States | — |
| UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange, California, United States | — |
| VA Palo Alto Health Care System | Palo Alto, California, United States | — |
| Boca Raton Regional Hospital | Boca Raton, Florida, United States | — |
| Baptist MD Anderson Cancer Center | Jacksonville, Florida, United States | — |
| Mayo Clinic in Florida | Jacksonville, Florida, United States | — |
| Moffitt Cancer Center-International Plaza | Tampa, Florida, United States | — |
+ 46 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03115333